Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.